An update of phase II results from RTOG 0211: A phase I/II study of Gefitinib plus radiation for newly-diagnosed glioblastoma patients

被引：4
|
作者：
Chakravarti, A.
Berkey, B.
Robins, H. I.
Guha, A.
Curran, W.
Brachman, D.
Shultz, C.
Mehta, M.
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Amer Coll Radiol, Philadelphia, PA USA
[3] Univ Wisconsin, Madison, WI USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Thomas Jefferson Med Coll, Philadelphia, PA USA
[6] Fdn Canc Res, Phoenix, AZ USA
[7] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
149
引用
收藏
页码：S83 / S84
页数：2
相关论文
共 50 条
  • [31] Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
    Butowski, Nicholas
    Chang, Susan M.
    Lamborn, Kathleen R.
    Polley, Mei-Yin
    Pieper, Russell
    Costello, Joseph F.
    Vandenberg, Scott
    Parvataneni, Rupa
    Nicole, Angelina
    Sneed, Patricia K.
    Clarke, Jennifer
    Hsieh, Emily
    Costa, Bruno M.
    Reis, Rui M.
    Hristova-Kazmierski, Maria
    Nicol, Steven J.
    Thornton, Donald E.
    Prados, Michael D.
    NEURO-ONCOLOGY, 2011, 13 (12) : 1331 - 1338
  • [32] Phase II study of tarceva plus temodar during and following radiotherapy in patients newly diagnosed with glioblastoma or gliosarcoma
    Prados, Michael
    DeBoer, Rebecca
    Chang, Susan
    Butowski, Nicholas
    Burton, Eric
    Rabbitt, Jane
    Page, Margaretta
    Fedoroff, Anne
    Carliner, Hannah
    Parvataneni, Rupa
    Kivett, Valerie
    Sneed, Penny
    Kabuubi, Paul
    Larson, David
    Berger, Mitchel
    McDermott, Michael
    Lamborn, Kathleen
    Stokoe, David
    Haas-Kogan, Daphne
    NEURO-ONCOLOGY, 2007, 9 (04) : 528 - 528
  • [33] Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial
    Grossman, Stuart A.
    Ye, Xiaobu
    Chamberlain, Marc
    Mikkelsen, Tom
    Batchelor, Tracy
    Desideri, Serena
    Piantadosi, Steven
    Fisher, Joy
    Fine, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) : 4155 - 4161
  • [34] A PHASE I STUDY OF SORAFENIB WITH RADIATION AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA
    Colman, Howard
    Gilbert, Mark
    Yung, W. K. Alfred
    Aldape, Ken
    De Groot, John
    Conrad, Charles
    Levin, Victor
    Groves, Morris
    Loghin, Monica
    Chris, Pelloski
    Puduvalli, Vinay
    NEURO-ONCOLOGY, 2011, 13 : 61 - 61
  • [35] A phase II study of plerixafor combined with whole brain radiation therapy (WBRT) for patients with newly diagnosed glioblastoma
    Cao, Toni
    Gu, Yuan
    Yagmurlu, Banu
    Yerraballa, Hari Priya
    Bertrand, Sophie
    Naya, Lewis
    Miller, Kate
    Iv, Michael
    Soltys, Scott G.
    Patel, Chirag B.
    Nagpal, Seema
    Thomas, Reena Parada
    Brown, Martin
    Recht, Lawrence David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] PHASE II STUDY OF AZELIRAGON IN COMBINATION WITH RADIATION THERAPY IN NEWLY DIAGNOSED PATIENTS WITH MGMT-UNMETHYLATED GLIOBLASTOMA
    Huang, Jiayi
    Ahluwalia, Manmeet
    Boockvar, John
    Batiste, James
    Jaboin, Jerry
    Thotala, Dinesh
    Halasz, Lia
    Rammohan, Nikhil
    Ney, Douglas
    Malani, Rachna
    Chinnaiyan, Prakash
    Kotecha, Rupesh R.
    Mehta, Minesh
    Marcus, Stephen
    NEURO-ONCOLOGY, 2024, 26
  • [37] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly diagnosed glioblastoma multiforme: Final results
    Peereboom, D. M.
    Brewer, C. J.
    Sub, J. H.
    Stevens, G. H.
    Barnett, G. H.
    Toms, S. A.
    Elson, P.
    Vogelbaum, M. A.
    Weil, R. J.
    NEURO-ONCOLOGY, 2006, 8 (04) : 448 - 448
  • [38] Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma -: A phase II study
    Weller, M
    Streffer, J
    Wick, W
    Kortmann, RD
    Heiss, E
    Küker, W
    Meyermann, R
    Dichgans, J
    Bamberg, M
    CANCER, 2001, 91 (02) : 423 - 427
  • [39] Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma
    Wen, PY
    Gigas, DC
    MacDonald, L
    Batchelor, TT
    Schiff, D
    Xu, R
    Ramakrishna, N
    Weaver, S
    Kracher, J
    Bradshaw, J
    Levy, B
    Bailey, E
    Kesari, S
    Maher, EA
    Henson, J
    Black, PM
    NEURO-ONCOLOGY, 2004, 6 (04) : 385 - 385
  • [40] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Bloch, Orin
    Chandler, James
    Tate, Matthew
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19
12345